Special Issue "Gut Microbial Dysbiosis in Disease Pathogenesis"
Deadline for manuscript submissions: 31 January 2024 | Viewed by 2079
Interests: microbiome; chronic inflammation; nutrition; cancer
Special Issues, Collections and Topics in MDPI journals
The gut microbiota is considered an invisible organ of the human system due to its multiple functional roles. There is no stable microbial composition, and the normal microbial composition varies between different age groups. This is an adaptive and dynamic system that reflects the health status and can be a potential biomarker in the future. The microbiota plays important role in training the immune system and various metabolic pathways. The overuse of antibiotics, poor diet, and lifestyle are some of the factors that affect the healthy microbial composition leading to microbial dysbiosis.
The role of microbial dysbiosis in causing diseases is clear from the increase in allergic and autoimmune diseases observed in developing countries as seen in developed countries. This is attributed to changes in diet and lifestyle that are considered to affect the microbiota.
With affordable next-generation sequencing, microbiome studies are conducted at small and large scales to explore various human diseases. Many such studies observed microbial dysbiosis in various disease conditions. These studies mostly profiled dysbiosis. Microbiome studies in the future are required to establish the mechanistic role of microbial dysbiosis in various disease pathogenesis.
This special issue invites original research and review articles that expand our knowledge on the role of dysbiosis in disease pathogenesis. The studies conducted in animal models and human subjects will be accepted for submission.
Dr. Pugazhendhi Srinivasan
Dr. Nanda Kumar Navalpur Shanmugam
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- fecal microbial transplant